Accès gratuit
Numéro
Med Sci (Paris)
Volume 21, Numéro 2, Février 2005
Page(s) 141 - 149
Section M/S revues
DOI https://doi.org/10.1051/medsci/2005212141
Publié en ligne 15 février 2005
  1. Glickman MH, Ciechanover A. The ubiquitin-proteasome proteolytic pathway : destruction for the sake of construction. Physiol Rev 2002; 82 : 373–428. [Google Scholar]
  2. Forster A, Hill CP. Proteasome degradation : enter the substrate. Trends Cell Biol 2003; 13 : 550–3. [Google Scholar]
  3. Orlowski M, Wilk S. Ubiquitin-independent proteolytic functions of the proteasome. Arch Biochem Biophys 2003; 415 : 1–5. [Google Scholar]
  4. Verma R, Deshaies RJ. A proteasome howdunit : the case of the missing signal. Cell 2000; 101 : 341–4. [Google Scholar]
  5. Asher G, Lotem J, Sachs L, et al. Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1. Proc Natl Acad Sci USA 2002; 99 : 13125–30. [Google Scholar]
  6. Ferrara P, Acquaviva C, Bossis G, et al. Protéolyse intracellulaire et tumorigenèse. Med Sci (Paris) 2001; 17 : 5–13. [Google Scholar]
  7. Coux O, Piechaczyk M. Le système ubiquitine/protéasome : un ensemble (de) complexe(s) pour dégrader les protéines. Med Sci (Paris) 2000; 16 : 623–9. [Google Scholar]
  8. Coux O. The 26S proteasome. Prog Mol Subcell Biol 2002; 29 : 85–107. [Google Scholar]
  9. Sun L, Chen ZJ. The novel functions of ubiquitination in signaling. Curr Opin Cell Biol 2004; 16 : 119–26. [Google Scholar]
  10. Pickart CM. Ubiquitin enters the new millennium. Mol Cell 2001; 8 : 499–504. [Google Scholar]
  11. Weissman AM. Themes and variations on ubiquitynation. Nat Rev Mol Cell Biol 2001; 2 : 169–78. [Google Scholar]
  12. Buchberger A. From UBA to UBX : new words in the ubiquitin vocabulary. Trends Cell Biol 2002; 12 : 216–21. [Google Scholar]
  13. Farras R, Bossis G, Andermarcher E, et al. Mechanisms of delivery of ubiquitinylated proteins to the proteasome : new targets for anti-cancer therapy. Crit Rev Oncol Hematol 2005 (sous presse). [Google Scholar]
  14. Hartmann-Petersen R, Seeger M, Gordon C. Transferring substrates to the 26S proteasome. Trends Biochem Sci 2003; 28 : 26–31. [Google Scholar]
  15. Deveraux Q, Ustrell V, Pickart C, Rechsteiner M. A 26 S protease subunit that binds ubiquitin conjugates. J Biol Chem 1994; 269 : 7059–61. [Google Scholar]
  16. Lam YA, Lawson TG, Velayutham M, et al. A proteasomal ATPase subunit recognizes the polyubiquitin degradation signal. Nature 2002; 416 : 763–7. [Google Scholar]
  17. Thrower JS, Hoffman L, Rechsteiner M, Pickart CM. Recognition of the polyubiquitin proteolytic signal. EMBO J 2000; 19 : 94–102. [Google Scholar]
  18. Yao T, Cohen RE. A cryptic protease couples deubiquitination and degradation by the proteasome. Nature 2002; 419 : 403–7. [Google Scholar]
  19. Verma R, Aravind L, Oania R, et al. Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome. Science 2002; 298 : 611–5. [Google Scholar]
  20. Kleijnen MF, Shih AH, Zhou P, et al. The hPLIC proteins may provide a link between the ubiquitination machinery and the proteasome. Mol Cell 2000; 6 : 409–19. [Google Scholar]
  21. Kleijnen MF, Alarcon RM, Howley PM. The ubiquitin-associated domain of hPLIC-2 interacts with the proteasome. Mol Biol Cell 2003; 14 : 3868–75. [Google Scholar]
  22. Sakata E, Yamaguchi Y, Kurimoto E, et al. Parkin binds the Rpn10 subunit of 26S proteasomes through its ubiquitin-like domain. EMBO Rep 2003; 4 : 301–6. [Google Scholar]
  23. Verma R, Chen S, Feldman R, et al. Proteasomal proteomics : identification of nucleotide-sensitive proteasome-interacting proteins by mass spectrometric analysis of affinity-purified proteasomes. Mol Biol Cell 2000; 11 : 3425–39. [Google Scholar]
  24. Leggett DS, Hanna J, Borodovsky A, et al. Multiple associated proteins regulate proteasome structure and function. Mol Cell 2002; 10 : 495–507. [Google Scholar]
  25. McClellan AJ, Frydman J. Molecular chaperones and the art of recognizing a lost cause. Nat Cell Biol 2001; 3 : E51–3. [Google Scholar]
  26. Sheaff RJ, Singer JD, Swanger J et al. Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination. Mol Cell 2000; 5 : 403–10. [Google Scholar]
  27. Touitou R, Richardson J, Bose S, et al. A degradation signal located in the C-terminus of p21WAF1/CIP1 is a binding site for the C8 alpha-subunit of the 20S proteasome. EMBO J 2001; 20 : 2367–75. [Google Scholar]
  28. Liu CW, Corboy MJ, DeMartino GN, Thomas PJ. Endoproteolytic activity of the proteasome. Science 2003; 299 : 408–11. [Google Scholar]
  29. Bloom J, Amador V, Bartolini F, et al. Proteasome-mediated degradation of p21 via N-terminal ubiquitinylation. Cell 2003; 115 : 71–82. [Google Scholar]
  30. Bornstein G, Bloom J, Sitry-Shevah D, et al. Role of the SCFSkp2 ubiquitin ligase in the degradation of p21Cip1 in S phase. J Biol Chem 2003; 278 : 25752–7. [Google Scholar]
  31. Bendjennat M, Boulaire J, Jascur T, et al. UV irradiation triggers ubiquitin-dependent degradation of p21(WAF1) to promote DNA repair. Cell 2003; 114 : 599–610. [Google Scholar]
  32. Bossis G, Ferrara P, Acquaviva C, et al. c-Fos proto-oncoprotein is degraded by the proteasome independently of its own ubiquitinylation in vivo. Mol Cell Biol 2003; 23 : 7425–36. [Google Scholar]
  33. Tanahashi N, Murakami Y, Minami Y, et al. Hybrid proteasomes. Induction by interferon-gamma and contribution to ATP-dependent proteolysis. J Biol Chem 2000; 275 : 14336–45. [Google Scholar]
  34. Ciechanover A, Schwartz AL. Ubiquitin-mediated degradation of cellular proteins in health and disease. Hepatology 2002; 35 : 3–6. [Google Scholar]
  35. Plemper RK, Hammond AL. Protein degradation in human disease. Prog Mol Subcell Biol 2002; 29 : 61–84. [Google Scholar]
  36. Pagano M, Benmaamar R. When protein destruction runs amok, malignancy is on the loose. Cancer Cell 2003; 4 : 251–6. [Google Scholar]
  37. Sherr CJ. Principles of tumor suppression. Cell 2004; 116 : 235–46. [Google Scholar]
  38. Liu YC. Ubiquitin ligases and the immune response. Annu Rev Immunol 2004; 22 : 81–127. [Google Scholar]
  39. Shackelford J, Pagano JS. Tumor viruses and cell signaling pathways : deubiquitination versus ubiquitination. Mol Cell Biol 2004; 24 : 5089–93. [Google Scholar]
  40. Adams J. The proteasome : a suitable antineoplastic target. Nat Rev Cancer 2004; 4 : 349–60. [Google Scholar]
  41. Jing Y. The PML-RARalpha fusion protein and targeted therapy for acute promyelocytic leukemia. Leuk Lymphoma 2004; 45 : 639–48. [Google Scholar]
  42. Zhang H, Burrows F. Targeting multiple signal transduction pathways through inhibition of Hsp90. J Mol Med 2004; 82 : 488–99. [Google Scholar]
  43. Kamal A, Boehm MF, Burrows FJ. Therapeutic and diagnostic implications of Hsp90 activation. Trends Mol Med 2004; 10 : 283–90. [Google Scholar]
  44. Zhang M, Pickart CM, Coffino P. Determinants of proteasome recognition of ornithine decarboxylase, a ubiquitin-independent substrate. EMBO J 2003; 22 : 1488–96. [Google Scholar]
  45. Krappmann D, Wulczyn FG, Scheidereit C. Different mechanisms control signal-induced degradation and basal turnover of the NF-kappaB inhibitor IkappaB alpha in vivo. EMBO J 1996; 15 : 6716–26. [Google Scholar]
  46. Forsthoelfel AM, Pena MMO, Xing YY, et al. Structural determinants of the intracellular degradation of human thymidylate synthase. Biochemistry 2004; 43 : 1972–9. [Google Scholar]
  47. Miller CL, Pintel DJ. The NS2 protein generated by the parvovirus minute virus of mice is degraded by the proteasome in a manner independent of ubiquitin chain elongation or activation. Virology 2001; 285 : 346–55. [Google Scholar]
  48. Kalejta RF, Shenk T. Proteasome-dependent, ubiquitin-independent degradation of the Rb family of tumor suppressors by the human cytomegalovirus pp71 protein. Proc Natl Acad Sci USA 2003; 100 : 3263–8. [Google Scholar]
  49. Shringarpure R, Grune T, Mehlhase J, Davies KJ. Ubiquitin conjugation is not required for the degradation of oxidized proteins by proteasome. J Biol Chem 2003; 278 : 311–8. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.